Positron Emission Tomography Response Criteria in Solid Tumors

Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST) makes use of positron emission tomography (PET) to provide functional information to help determine tumor viability.

The criteria consist of four categories: complete metabolic response (CMR), partial metabolic response (PMR), progressive metabolic disease (PMD), and stable metabolic disease (SMD). 

As used below, SUL is the standardized uptake value corrected for lean body mass. SULpeak (or SULpeak) is the peak SUL in a spherical 1 cm3 volume of interest (VOI).

  • complete resolution of 18F-FDG uptake within the measurable target lesion

    • so that it is less than mean liver activity
    • so that it is at the level of surrounding background blood pool activity
  • disappearance of all other lesions to background blood pool levels
  • no new suspicious 18F-FDG avid lesions
  • if progression according to RECIST criteria, must verify with follow up
  • reduction of a minimum of 30% in target measurable tumor 18F-FDG SUL peak, with absolute drop in SUL of at least 0.8 SUL units.
  • no increase >30% of SUL or size in all other lesions
  • no new lesions
  • no CMR, PMR, or progressive metabolic disease (PMD)
  • no new lesions
  • >30% increase in 18F-FDG SUL peak, with >0.8 SUL units increase in tumor SUL from the baseline scan in pattern typical of tumor and not of infection/treatment effect
  • or visible increase in the extent of 18F-FDG tumor uptake.
  • or new 18F-FDG avid lesions typical of cancer and not related to treatment effect and/or infection.
Share article

Article information

rID: 57911
System: Oncology
Section: Staging
Synonyms or Alternate Spellings:
  • Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST)

Support Radiopaedia and see fewer ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.